Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2001

View Archived Issues

Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia

Dual PPAR agonist shows good preclinical results

Companies form strategic agreement to develop asthma and allergic rhinitis products

Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions

Final results of PH-10 pilot study in the treatment of plaque psoriasis reported

Theratechnologies submits IND application to Health Canada for ThGRF1-44

Osteoarthritis product launched in Europe

Biora enters distribution agreement with USBiomaterials for new periodontal disease product

New selective dopamine D4 complete antagonist reported

Genetically modified neural stem cells may be useful in the treatment of PD

Avanir acquires technology to develop MIF modulators

Roche receives first approval for PEGASYS

Schering AG acquires rights to fasudil in the U.S. and Europe

Antalarmin inhibits stress-induced gastric ulceration in rats

New cathepsin and calpain inhibitors and their use described by Senju

Urokinase inhibitors with antiangiogenic activity reported by Abbott

Kyoto Pharmaceutical reports new derivatives with glucose- and triglyceride-lowering activity

Novel thrombin inhibitors presented by Akzo Nobel

Sumitomo describes new compounds for the treatment of inflammation and autoimmune diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...